The Latest Breaking News from FDA

PHILADELPHIA -- Philadelphia’s most prominent immunization expert isn’t planning to get the latest COVID-19 booster shot, and doesn’t think most others need to either.

Gainers

Biopharmaceutical giant Gilead Sciences (GILD) reported better-than-expected third-quarter earnings and sales and raised its full-year guidance. Analysts see immense growth potential in the company’s HIV and oncology franchises, which should boost its performance in the upcoming quarters. Given its strong earnings, high profitability, discounted valuation, and attractive dividend, we think…

Benzene is a chemical which can raise the risk of some cancers after long-term exposure

The Fed announced its fourth consecutive 75-bps rate hike this week. However, the Fed's aggression is expected to shrink eventually. Amid rampant market volatility, investor sentiment toward dividend stocks is robust. Therefore, fundamentally sound stocks Pfizer (PFE) and Caledonia Mining (CMCL) could be solid picks for a steady income stream.…

Leading biopharmaceutical company AbbVie Inc. (ABBV) is well-positioned to benefit from its diversified portfolio, research breakthroughs, drug and therapy approvals, acquisitions, and partnerships. The company has been increasingly paying dividends, supported by its stable earnings stream. Therefore, investors looking for passive income amid uncertain market conditions could invest in this…

The lone volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him

Pfizer says its updated COVID-19 booster significantly revved up adults' virus-fighting antibodies

Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry.